Alternative splicing in serotonergic system: Implications in neuropsychiatric disorders

  title={Alternative splicing in serotonergic system: Implications in neuropsychiatric disorders},
  author={Eva Latorre and Jos{\'e} Emilio Mesonero and Lorna W. Harries},
  journal={Journal of Psychopharmacology},
  pages={1352 - 1363}
Background: The serotonergic system is a key component of physiological brain function and is essential for proper neurological activity. Numerous neuropsychiatric disorders are associated with deregulation of the serotonergic system. Accordingly, many pharmacological treatments are focused on modulation of this system. While providing a promising line of therapeutic moderation, these approaches may be complicated due to the presence of alternative splicing events for key genes in this pathway… 

Figures and Tables from this paper

Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management

The aim of this review is to evaluate the current evidence about neurotransmitter dysfunction in IBS and explore the potential therapeutic approaches, including novel pharmacological approaches such as 5- HT3 receptor antagonists and 5-HT4 receptor agonists, which could provide promising new approaches for IBS management.

The splicing switch of SLK controls tumor progression partially via different associations with occludin

The biological consequences and underlying mechanisms for one of the most mis-spliced genes in cancer are uncovered, shedding light on new cancer therapy via splicing manipulation and using antisense oligonucleotides to inhibit the inclusion of SLK exon 13.

An Improved CRISPR/dCas9 Interference Tool for Neuronal Gene Suppression

These findings advance this improved CRISPRi technology for use in neuronal systems for the first time, potentially enabling improved ability to manipulate gene expression states in the nervous system.



A functional alternative splicing mutation in human tryptophan hydroxylase-2

A common, but functional single-nucleotide polymorphism (SNP rs1386493) in the TPH2 gene is characterized, which decreases efficiency of normal RNA splicing, resulting in a truncated T PH2 protein (TPH2-TR) by alternative splicing.

5-HT2C receptors in psychiatric disorders: A review

Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice

Mice lacking key components of the serotonin system have provided important animal models of genetic vulnerability to conditions such as anxiety disorders, aggression, and drug abuse and ongoing research with these mice may help elucidate the mechanistic functioning of this complex system.

Alternative Splicing and Extensive RNA Editing of Human TPH2 Transcripts

Results strongly suggest a complex fine-tuning of central nervous system 5-HT biosynthesis by TPH2 alternative splicing and RNA editing, involved in the etiology of psychiatric diseases, such as suicidal behaviour.

Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression

The findings suggest that TPH2 polymorphisms characterize a subgroup of depressed patients who are especially prone to develop metabolic disorders induced by a genotype-dependent impairment of serotonergic neurotransmission.

Tryptophan hydroxylase-2: an emerging therapeutic target for stress disorders.

Alterations of Expression of the Serotonin 5-HT4 Receptor in Brain Disorders

The current knowledge of 5-HT4R expression in brain regions relevant to mood/depression, reward and executive function is presented, with a focus on5-HT 4R expression changes in brain disorders or caused by drug treatment, at both the transcript and protein levels.